SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Oppenheimer Initiates Coverage On Intersect ENT with Perform Rating

Oppenheimer analyst Suraj Kalia initiates coverage on Intersect ENT (NASDAQ:XENT) with a Perform rating.

Benzinga · -
Oppenheimer analyst Suraj Kalia initiates coverage on Intersect ENT (NASDAQ: XENT) with a Perform rating.